RECRUITING

Genetic Collection Protocol

Talk to us

Conditions

Liver Diseases

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study involves the one-time collection of whole blood or saliva samples for the extraction and storage of DNA for use in ongoing and future ChiLDReN studies.

Official Title

Genetic Collection Protocol

Quick Facts

Study Start:2022-04-06
Study Completion:2029-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05272319

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:24 Hours to 25 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * For Child Participants
  2. 1. Previous enrollment in PROBE, BASIC, LOGIC, or MITOHEP
  3. 2. Exited from one of the aforementioned studies.
  4. 3. Consent for DNA sample collection obtained during enrollment during enrollment to one of the aforementioned studies but sample not previously collected.
  5. 4. Still followed at the clinical site.
  6. * For Biological Parent Participants
  7. 1. Biological parents of previously consented child participant without collection of a parental DNA biospecimen.
  8. 2. Child still followed at the clinical site.
  1. * For Child Participants
  2. 1. Participant is deceased
  3. 2. Participant exited from prior study due to violating eligibility criteria
  4. 3. Participant cannot be contacted
  5. * For Biological Parent Participants
  6. 1. Non-biological parent
  7. 2. Child DNA was not previously collected and will not be collected in this study

Contacts and Locations

Study Contact

Terese A Howell, BS
CONTACT
734-476-5340
terri.howell@aborresearch.org
Sayori Suda-Wilson, BS, RD
CONTACT
734-678-5070
sayori.suda-wilson@arborresearch.org

Principal Investigator

Ed Doo, MD
STUDY_DIRECTOR
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Averell Sherker, MD
STUDY_DIRECTOR
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
John Magee, MD
PRINCIPAL_INVESTIGATOR
University of Michigan
Lisa Henn, PhD
PRINCIPAL_INVESTIGATOR
Arbor Research Collaborative for Health

Study Locations (Sites)

Children's Hospital of Los Angeles
Los Angeles, California, 90027
United States
UCSF Benioff Children's Hospital
San Francisco, California, 94143
United States
Children's Hospital Colorado
Aurora, Colorado, 80045
United States
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322
United States
Lurie Children's Hospital
Chicago, Illinois, 60611
United States
Riley Hospital for Children
Indianapolis, Indiana, 46202
United States
Cincinnati Children's Hospital
Cincinnati, Ohio, 45229
United States
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104
United States
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224
United States
Texas Children's Hospital; Baylor College of Medicine
Houston, Texas, 77030
United States
University of Utah
Salt Lake City, Utah, 84113
United States
Seattle Children's Hospital
Seattle, Washington, 98105
United States

Collaborators and Investigators

Sponsor: Arbor Research Collaborative for Health

  • Ed Doo, MD, STUDY_DIRECTOR, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Averell Sherker, MD, STUDY_DIRECTOR, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • John Magee, MD, PRINCIPAL_INVESTIGATOR, University of Michigan
  • Lisa Henn, PhD, PRINCIPAL_INVESTIGATOR, Arbor Research Collaborative for Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-04-06
Study Completion Date2029-05-31

Study Record Updates

Study Start Date2022-04-06
Study Completion Date2029-05-31

Terms related to this study

Additional Relevant MeSH Terms

  • Liver Diseases